|
1
|
International Agency for Research on
Cancer: Population Fact Sheets: World. http://gco.iarc.fr/today/fact-sheets-populations?population=900&sex=0July
25–2017.
|
|
2
|
Siegel R, DeSantis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sankaranarayanan R, Swaminathan R, Brenner
H, Chen K, Chia KS, Chen JG, Law SC, Ahn YO, Xiang YB, Yeole BB, et
al: Cancer survival in Africa, Asia, and Central America: A
population-based study. Lancet Oncol. 11:165–173. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heald RJ and Ryall RD: Recurrence and
survival after total mesorectal excision for rectal cancer. Lancet.
1:1479–1482. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van Gijn W, Marijnen CAM, Nagtegaal ID,
Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius
B and van de Velde CJ; Dutch Colorectal Cancer Group: Preoperative
radiotherapy combined with total mesorectal excision for resectable
rectal cancer: 12-year follow-up of the multicentre, randomised
controlled TME trial. Lancet Oncol. 12:575–582. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Polónia A, Coimbra M, Reis S, Tavares A,
Raimundo A, Santos LL, Jeronimo C and Henrique RM: Expression of
histone modifying enzymes and histone post-translational marks in
colorectal cancer. Virchows Arch. 463:1252013.
|
|
7
|
Barker HE, Cox TR and Erler JT: The
rationale for targeting the LOX family in cancer. Nat Rev Cancer.
12:540–552. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ikenaga N, Peng ZW, Vaid KA, Liu SB,
Yoshida S, Sverdlov DY, Mikels-Vigdal A, Smith V, Schuppan D and
Popov YV: Selective targeting of lysyl oxidase-like 2 (LOXL2)
suppresses hepatic fibrosis progression and accelerates its
reversal. Gut. 66:1697–1708. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang J, Savvatis K, Kang JS, Fan P, Zhong
H, Schwartz K, Barry V, Mikels-Vigdal A, Karpinski S, Kornyeyev D,
et al: Targeting LOXL2 for cardiac interstitial fibrosis and heart
failure treatment. Nat Commun. 7:137102016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu L and Zhu Y: The function and
mechanisms of action of LOXL2 in cancer (Review). Int J Mol Med.
36:1200–1204. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park JS, Lee JH, Lee YS, Kim JK, Dong SM
and Yoon DS: Emerging role of LOXL2 in the promotion of pancreas
cancer metastasis. Oncotarget. 7:42539–42552. 2016.PubMed/NCBI
|
|
12
|
Torres S, Garcia-Palmero I, Herrera M,
Bartolomé RA, Peña C, Fernandez-Aceñero MJ, Padilla G,
Peláez-García A, Lopez-Lucendo M, Rodriguez-Merlo R, et al: LOXL2
is highly expressed in cancer-associated fibroblasts and associates
to poor colon cancer survival. Clin Cancer Res. 21:4892–4902. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wong CC, Tse AP, Huang YP, Zhu YT, Chiu
DK, Lai RK, Au SL, Kai AK, Lee JM, Wei LL, et al: Lysyl
oxidase-like 2 is critical to tumor microenvironment and metastatic
niche formation in hepatocellular carcinoma. Hepatology.
60:1645–1658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moreno-Bueno G, Salvador F, Martín A,
Floristán A, Cuevas EP, Santos V, Montes A, Morales S, Castilla MA,
Rojo-Sebastián A, et al: Lysyl oxidase-like 2 (LOXL2), a new
regulator of cell polarity required for metastatic dissemination of
basal-like breast carcinomas. EMBO Mol Med. 3:528–544. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fu J, Tang W, Du P, Wang G, Chen W, Li J,
Zhu Y, Gao J and Cui L: Identifying microRNA-mRNA regulatory
network in colorectal cancer by a combination of expression profile
and bioinformatics analysis. BMC Syst Biol. 6:682012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui X, Liu B, Zheng S, Dong K and Dong R:
Genome-wide analysis of DNA methylation in hepatoblastoma tissues.
Oncol Lett. 12:1529–1534. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang G, Shen W, Liu CY, Liu Y, Wu T, Cui
X, Yu T, Zhu Y, Song J, Du P, et al: Phosphorylase kinase β affects
colorectal cancer cell growth and represents a novel prognostic
biomarker. J Cancer Res Clin Oncol. 143:971–980. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui X, Yang Y, Jia D, Jing Y, Zhang S,
Zheng S, Cui L, Dong R and Dong K: Downregulation of bone
morphogenetic protein receptor 2 promotes the development of
neuroblastoma. Biochem Biophys Res Commun. 483:609–616. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wiederschain D, Wee S, Chen L, Loo A, Yang
G, Huang A, Chen Y, Caponigro G, Yao YM, Lengauer C, et al:
Single-vector inducible lentiviral RNAi system for oncology target
validation. Cell Cycle. 8:498–504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu CY, Yu T, Huang Y, Cui L and Hong W:
ETS (E26 transformation-specific) up-regulation of the
transcriptional co-activator TAZ promotes cell migration and
metastasis in prostate cancer. J Biol Chem. 292:9420–9430. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Y, Wang G, Yang Y, Mei Z, Liang Z, Cui
A, Wu T, Liu CY and Cui L: Increased TEAD4 expression and nuclear
localization in colorectal cancer promote epithelial-mesenchymal
transition and metastasis in a YAP-independent manner. Oncogene.
35:2789–2800. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Findlay VJ, Wang C, Nogueira LM, Hurst K,
Quirk D, Ethier SP, Staveley O'Carroll KF, Watson DK and Camp ER:
SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity
through miR145 repression. Mol Cancer Ther. 13:2713–2726. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Terret ME, Lefebvre C, Djiane A, Rassinier
P, Moreau J, Maro B and Verlhac MH: DOC1R: A MAP kinase substrate
that control microtubule organization of metaphase II mouse
oocytes. Development. 130:5169–5177. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu SB, Ikenaga N, Peng ZW, Sverdlov DY,
Greenstein A, Smith V, Schuppan D and Popov Y: Lysyl oxidase
activity contributes to collagen stabilization during liver
fibrosis progression and limits spontaneous fibrosis reversal in
mice. FASEB J. 30:1599–1609. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Barry-Hamilton V, Spangler R, Marshall D,
McCauley S, Rodriguez HM, Oyasu M, Mikels A, Vaysberg M, Ghermazien
H, Wai C, et al: Allosteric inhibition of lysyl oxidase-like-2
impedes the development of a pathologic microenvironment. Nat Med.
16:1009–1017. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Barker HE, Chang J, Cox TR, Lang G, Bird
D, Nicolau M, Evans HR, Gartland A and Erler JT: LOXL2-mediated
matrix remodeling in metastasis and mammary gland involution.
Cancer Res. 71:1561–1572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kouhkan F, Motovali-Bashi M and Hojati Z:
The influence of interstitial collagenase-1 genotype polymorphism
on colorectal cancer risk in Iranian population. Cancer Invest.
26:836–842. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park PG, Jo SJ, Kim MJ, Kim HJ, Lee JH,
Park CK, Kim H, Lee KY, Kim H, Park JH, et al: Role of LOXL2 in the
epithelial-mesenchymal transition and colorectal cancer metastasis.
Oncotarget. 8:80325–80335. 2017.PubMed/NCBI
|
|
29
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Peinado H, Del Carmen Iglesias-de la Cruz
M, Olmeda D, Csiszar K, Fong KS, Vega S, Nieto MA, Cano A and
Portillo F: A molecular role for lysyl oxidase-like 2 enzyme in
snail regulation and tumor progression. EMBO J. 24:3446–3458. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hecht JR, Benson AB III, Vyushkov D, Yang
Y, Bendell J and Verma U: A phase II, randomized, double-blind,
placebo-controlled study of simtuzumab in combination with FOLFIRI
for the second-line treatment of metastatic KRAS mutant colorectal
adenocarcinoma. Oncologist. 22:243–e23. 2017. View Article : Google Scholar : PubMed/NCBI
|
